Author:
Wei Zhen,Liu Xiaoyi,Cheng Chunming,Yu Wei,Yi Ping
Abstract
Metabolic reprogramming has been widely recognized as a hallmark of malignancy. The uptake and metabolism of amino acids are aberrantly upregulated in many cancers that display addiction to particular amino acids. Amino acids facilitate the survival and proliferation of cancer cells under genotoxic, oxidative, and nutritional stress. Thus, targeting amino acid metabolism is becoming a potential therapeutic strategy for cancer patients. In this review, we will systematically summarize the recent progress of amino acid metabolism in malignancy and discuss their interconnection with mammalian target of rapamycin complex 1 (mTORC1) signaling, epigenetic modification, tumor growth and immunity, and ferroptosis. Finally, we will highlight the potential therapeutic applications.
Funder
National Natural Science Foundation of China
Subject
Cell Biology,Developmental Biology
Reference336 articles.
1. CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines;Abdelmagid;J. Cell. Biochem.,2011
2. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study;Abou-Alfa;Lancet Oncol.,2020
3. Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma;Abou-Alfa;Ann. Oncol.,2018
4. Lysine acetylation goes global: from epigenetics to metabolism and therapeutics;Ali;Chem. Rev.,2018
5. From Krebs to clinic: glutamine metabolism to cancer therapy;Altman;Nat. Rev. Cancer,2016
Cited by
223 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献